Analytical Data
-
Gene name
STKLD1
- Application
-
Alternative Names
C9orf96; SGK071
-
Species
Human
-
Source
Baculovirus
-
Tag
His;GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NE28-1
-
Expression Region
L2-E680
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
STKLD1 (Serine/Threonine Kinase-Like Domain Containing 1) is a relatively newly identified protein that has garnered attention due to its potential implications in various biological processes and diseases. Recent studies suggest that STKLD1 may play a role in cell signaling pathways, particularly those related to growth and differentiation, making it a candidate for research in cancer biology and developmental processes. Its structure features kinase-like domains, which hint at possible enzymatic activity, although its exact functional roles remain largely unclear. Researchers are particularly interested in the implications of STKLD1 in the context of tumorigenesis, where aberrant signaling pathways can lead to uncontrolled cell proliferation. Additionally, STKLD1's interactions with other signaling molecules and proteins could provide insights into its regulatory mechanisms. Understanding the molecular function of STKLD1 and its associated pathways could contribute to the development of novel therapeutic strategies, especially in cancer treatment, where targeted therapies are increasingly crucial. Overall, the recombinant expression and characterization of STKLD1 are essential steps toward elucidating its biological significance and therapeutic potential.
